D-Allose-13C-2

CAT:
804-HY-128741S2-01
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
D-Allose-13C-2 - image 1

D-Allose-13C-2

  • Description:

    D-Allose-13C-2 is the 13C labeled D-Allose (HY-128741) . D-Allose exhibits antitumor activity against various cancer cells. D-Allose scavenges reactive oxygen species (ROS) and reduces oxidative stress damage. D-Allose exhibits anti-inflammatory and neuroprotective through inhibition of TLR4/PI3K/AKT signaling pathway. D-Allose exhibits antihypertensive, cryoprotective, and anti-osteoporotic activities[1][2][5].
  • UNSPSC:

    12352211
  • Target:

    Akt; Apoptosis; Endogenous Metabolite; Isotope-Labeled Compounds; PI3K; Reactive Oxygen Species (ROS)
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others; PI3K/Akt/mTOR
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/d-allose-13c-2.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O=C[C@@H]([C@@H]([13C@@H]([C@@H](CO)O)O)O)O
  • Molecular Formula:

    C5 13CH12O6
  • Molecular Weight:

    181.15
  • References & Citations:

    [1]Chen Z, et al., Recent research on the physiological functions, applications, and biotechnological production of D-allose. Appl Microbiol Biotechnol. 2018 May;102 (10) :4269-4278. |[2]Sui L, et al., Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro. Anticancer Res. 2005 Jul-Aug;25 (4) :2639-44.|[3]Gao D, et al., Anti-inflammatory effect of D-allose in cerebral ischemia/reperfusion injury in rats. Neurol Med Chir (Tokyo) . 2013;53 (6) :365-74.|[4]Akumwami S, et al., Effects of D-Allose on experimental cardiac hypertrophy. J Pharmacol Sci. 2024 Oct;156 (2) :142-148.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported